Kendall Capital Management - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 212 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2022. The put-call ratio across all filers is 1.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
Kendall Capital Management ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q4 2022$119
-100.0%
10,115
-11.2%
0.06%
-56.8%
Q3 2022$239,000
-32.5%
11,3950.0%0.14%
-28.7%
Q2 2022$354,000
-25.6%
11,395
-1.6%
0.20%
-15.2%
Q1 2022$476,000
-1.0%
11,585
+4.7%
0.23%
+0.9%
Q4 2021$481,000
+20.0%
11,060
+38.2%
0.23%
+5.1%
Q3 2021$401,000
+44.8%
8,005
+82.1%
0.22%
+39.1%
Q2 2021$277,0004,3950.16%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Zebra Capital Management LLC 25,250$784,0002.30%
Global Alpha Capital Management Ltd. 418,030$12,976,0001.40%
AIMZ Investment Advisors, LLC 70,588$2,191,0001.05%
PALISADE CAPITAL MANAGEMENT, LP 566,080$17,571,0000.48%
RICE HALL JAMES & ASSOCIATES, LLC 261,533$8,118,0000.39%
EARNEST PARTNERS LLC 1,844,621$57,257,0000.38%
SummerHaven Investment Management, LLC 14,476$449,0000.30%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,085,874$33,706,0000.26%
Ridgewood Investments LLC 10,004$311,0000.24%
DUALITY ADVISERS, LP 65,650$2,038,0000.20%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders